ASCIA Annual Conference

ASCIA 2021 Conference Update

ASCIA2021 VIRTUAL Conference

ASCIA 2021 Conference 

It is a pleasure to invite you to participate in the ASCIA 2021 Conference, which is being hosted as a virtual event from Wednesday 1st to Friday 3rd September 2021.

To view the program go to https://ascia2021.com/program.php

The ASCIA 2021 Conference will provide registered delegates with:

  • An international standard of CPD/CME, with more than 60 speakers, including 12 international experts, 73 poster presentations, 20 CGR presentations and 18 sponsored sessions.
  • Access to view sessions at any time, as recordings will be available on the conference platform. If attending ‘live’, delegates can participate in online live Q&A sessions.
  • Access to concurrent programs for Nurses, Dietitians and Associate Medical Days on Friday.  
  • Complimentary registration for ASCIA 2021 Conference dinner meetings on Thursday 2nd September which will be held in Adelaide, Auckland, Brisbane, Canberra, Melbourne, Newcastle, Perth and Sydney.
  • An update on research projects funded from 2015-2019 by the Allergy and Immunology Foundation of Australasia (AIFA).
  • Access to updates about new products in 18 sponsored sessions and in the 3D virtual exhibition.
  • Exceptional value, with reasonably priced registration fees that have been made possible due to support from ASCIA 2021 Sponsors and Exhibitors.

The ASCIA 2021 Conference program includes presentations by 12 international keynote speakers:

  • Dr Kimberly Blumenthal (USA) - IgE Mediated Drug Allergy Reactions
  • Prof Wen-Hung Chung (Taiwan) - T Cell Mediated Drug Reactions and Novel Technologies
  • Dr Andrew Gennery (UK) - TAPID Collaboration from a UK Perspective
  • Prof David Khan (USA) - Re-Labelling Drug Allergy
  • Prof Mark Little (Ireland) - Targeting Subclinical-Immune Pathology in ANCA Vasculitis
  • Dr Rosan Meyer (UK) - Avoidant/Restrictive Food Intake Disorder (ARFID) 
  • Prof Antonella Muraro (Italy) - Pathogenesis of Food Allergy
  • Prof Elizabeth Philips (USA) - Excipient Allergy
  • Dr Kathleen Sullivan (USA) - COVID-19 and Syndromes in Children, Rubella Associated Granuloma
  • A/Prof Bernard Thong (Singapore) - COVID-19 Vaccine Immediate Reactions
  • A/Prof Paul Turner (UK) - Anaphylaxis and Food Allergy, COVID-19 Vaccine Delayed Reactions COVID-19 in 2021 and Beyond, Food Allergy Prevention in 2021 and Beyond
  • A/Prof Carina Venter (USA) - Food Allergy and Diet, Maternal Diet and Food Allergy Prevention in Children.

For more details about these speakers go to https://ascia2021.com/international-speakers.php  

The ASCIA 2021 Conference program also features presentations by local keynote speakers, including:

  • Dr Katie Allen MP - 2021 Basten Oration - A Journey from Benchside to Bedside, and Population to Politics - Why would you do it? 
  • Prof Anthony Kelleher - Long COVID
  • Prof Connie Katelaris AM - Climate Change and Allergy
  • Dr Jennifer Koplin - Food Allergy Prevention - EarlyNuts Study Results
  • A/Prof Philip Robinson - Autoimmunity and COVID-19
  • Dr Charlotte Slade - Primary Immunodeficiency in the Adult and Elderly Population
  • Dr Norman Swan - 2021 Dinner Speaker - Medicine and the Media - What have we learnt since March 2020? 
  • Prof Mimi Tang - Food Allergy Treatment - Peanut Allergy OIT Trial Results
  • Prof Stuart Tangye - Immunodeficiency and COVID-19            
  • Prof Carola Vinuesa - Neuritin to Prevent Autoimmune Disease and Allergies

ASCIA works in collaboration with other medical specialists and organisations, and this is reflected in the ASCIA 2021 Conference program, which includes the following sessions:

  • ASCIA-CFAR (Centre for Food and Allergy Research) Symposium on Wednesday.
  • ASCIA-ANZVASC (Australia and New Zealand Vasculitis Society) Symposium on Friday.
  • ASCIA Immunodeficiency Strategy for Australia and New Zealand Update on Friday.
  • National Allergy Strategy Update on Friday.

We greatly appreciate support from the ASCIA 2021 Conference sponsors and exhibitors. There will be sponsored sessions each morning and on Wednesday evening, and a 3D virtual exhibition each day. To view options for support go to https://www.ascia2021.com/sponsorship-and-exhibition.php

With an outstanding program and innovative virtual format, we expect that the ASCIA 2021 Conference will provide an international standard of education and networking opportunities for ASCIA members and other health professionals with an interest in allergy and clinical immunology.

We look forward to your involvement in the ASCIA 2021 Conference.

Kind regards,

Prof Michaela Lucas         Jill Smith 
ASCIA President        ASCIA CEO

On behalf of the ASCIA 2021 Conference committee:

ASCIA 2021 Conference committee

Chair - Prof Michaela Lucas (WA) 

Members

ASCIA Directors: Dr Theresa Cole (VIC), A/Prof Jane Peake (QLD), Dr Michael O'Sullivan (WA).

ASCIA Committee Chairs: Dr Karl Baumgart (NSW), Dr Lara Ford (NSW), Dr Katie Frith (NSW), Prof Connie Katelaris AM (NSW), Dr Kathryn Patchett (NSW),

ASCIA Associate Representatives: Kathy Beck (QLD), Dr Kathryn Heyworth (QLD), Dr Hannah Hu (NSW), Briony Tyquin (NSW).

Other members: Dr Tiffany Hughes (SA), Dr Preeti Joshi (NSW), Dr Dean Tey (VIC), Dr Brynn Wainstein (NSW), Dr Melanie Wong (NSW).

Thursday evening dinner meetings (restrictions permitting) will be coordinated by the ASCIA Council Area Representatives for each region: 
Dr Andrew Baker (NZ), Dr Elizabeth da Silva (ACT), Dr Narinder Kaur (NSW), Dr Jovanka King (SA), Dr Alberto Pinzon (QLD), Dr Stephanie Richards (VIC), A/Prof Kristina Rueter (WA).


Other Conference Information

Content updated July 2021 

Mod ASCIA Member
Donate to AIFA
go to NAS website
ASCIA Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:

About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.